遺伝子ノックアウト細胞株 検証済
リコンビナント
RabMAb

Anti-TAK1 抗体 [EPR5984] (ab109526)

ab109526 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab109526 は 5 報の論文で使用されています。

  • Cheng J  et al. Inhibition of transforming growth factor ß-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis. Sci Rep 6:34497 (2016). IHC-P . PubMed: 27682596
  • Li XJ  et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-?B signaling pathways in osteoprotegerin knockout mice. Int J Mol Med N/A:N/A (2016). WB ; Mouse . PubMed: 27840967
  • Wang C  et al. HTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin Chains. PLoS Pathog 12:e1005584 (2016). PubMed: 27082114
  • Zhang X  et al. Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfß) Signal Pathway. Med Sci Monit 22:1516-23 (2016). WB . PubMed: 27145790
  • Gu M  et al. Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation. J Immunol 192:2846-56 (2014). PubMed: 24534530

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録